pramipexole
We evaluated the efficacy of the nonergot dopamine receptor agonist pramipexole       in 16 patients with advanced Parkinson's disease and marked rest tremor during an       "on" period.
We evaluated the efficacy of the nonergot dopamine receptor agonist  @SUBJECT$         @PREDICAT$  16  @OBJECT$  with advanced Parkinson's disease and marked rest tremor during an       "on" period.